Live Breaking News & Updates on Consultant For The Gerson Lehman Group|Page 1

Stay updated with breaking news from Consultant for the gerson lehman group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Celsion Corporation Reports 2020 Financial Results and Provides Business Update

Celsion Corporation Reports 2020 Financial Results and Provides Business Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New Jersey , United States , Michaelh Tardugno , Xinzhen Yang , Britta Glaunsinger , Kim Sutton Golodetz , University Of California , Consultant For The Gerson Lehman Group , Celsion Corporation , Jersey Economic Development Authority , Development Agreement , Jeffreyw Church , National Institutes Of Health , Vaccine Program At Pfizer Inc , Drug Administration , Data Monitoring Committee , International Toll , Vaccine Initiative , Technology Business Tax Certificate , Viral Vaccines Program , Exchange Commission , Howard Hughes Medical Institute , Next Generation Infectious Vaccines , Strong Balance , Call Begins , Encouraging Interim Clinical Update ,

Celsion Corporation Announces Formation of Vaccine Advisory Board

Britt A. Glaunsinger, Ph.D., Professor, Virology & Molecular Biology, Howard Hughes Medical Institute, University of California, Berkeley, and

Dr. Xinzhen Yang, M.D., Ph.D., Independent Professional Consultant for the Gerson Lehman Group and former Director of Viral Vaccines / Program Lead of the HCMV Vaccine Program at Pfizer Inc.
“We are delighted to launch our Vaccine Advisory Board with these impressive scientists as charter members,” said Michael H. Tardugno, Celsion’s chairman, president and chief executive officer. “We view Drs. Glaunsinger’s and Yang’s agreement to advise us on the development of our TheraPlas technology-based PLACCINE DNA vaccine platform for the prevention and treatment of COVID-19 and other dangerous viruses as a vote of confidence in our technology. We look forward to adding more talented individuals to this advisory board, as well as to making key internal hires as we advance this promising platform.” ....

United States , San Francisco , Xinzhen Yang , Michaelh Tardugno , Britta Glaunsinger , American Society For Microbiology , University Of California , Consultant For The Gerson Lehman Group , Celsion Corporation , Gerson Lehman Group , Rapid Research Response Scientific Advisory Board , Shanghai Medical University , Vaccine Technical Review Committee , Chinese Academy Of Preventive Medicine , Innovative Genomics Institute , Baylor College Of Medicine , Vaccine Program At Pfizer Inc , Harvard Medical School , American Society For Virology , Viral Vaccines Program , Vaccine Clinical Review Committee , Catalyst Fund , Fudan University , University Of Arizona , Company Theraplas , Howard Hughes Medical Institute ,